Clinical Trial Update: Omega-3 Fatty Acids in Autism Spectrum Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating omega-3 fatty acids in individuals with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: National Healthcare Group, Singapore | Conditions: Autism Spectrum Disorders | Phase 4 | Status: COMPLETED